Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus
Clinical trial NCT07381465 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07381465
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2027-12-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.